Ipilimumab

Nat Rev Drug Discov. 2011 Jun;10(6):411-2. doi: 10.1038/nrd3463.
No abstract available

Publication types

  • News

MeSH terms

  • Animals
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use*
  • Antigens, CD / immunology
  • CTLA-4 Antigen
  • Humans
  • Ipilimumab
  • Melanoma / drug therapy*
  • Melanoma / immunology
  • Melanoma / secondary

Substances

  • Antibodies, Monoclonal
  • Antigens, CD
  • CTLA-4 Antigen
  • CTLA4 protein, human
  • Ipilimumab